Filing Details

Accession Number:
0001615774-16-007184
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-14 18:30:54
Reporting Period:
2016-09-13
Filing Date:
2016-09-14
Accepted Time:
2016-09-14 18:30:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1430306 Tonix Pharmaceuticals Holding Corp. TNXP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1180469 Ernest Mario C/O Tonix Pharmaceuticals Holding Corp.
509 Madison Avenue, Suite 306
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2016-09-13 100,000 $0.79 530,724 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.791817611. The range of purchase prices on the transaction date was $0.7801 to $0.80 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.